γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

BACKGROUND: Anti-CD20 monoclonal antibodies are major therapeutic agents for patients with follicular lymphoma and work through complement-mediated cytotoxicity and antibody-dependent cellular cytotoxicity. Optimization of antibody-dependent cellular cytotoxicity, in particular by amplifying its eff...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Braza, Mounia Sabrina, Klein, Bernard, Fiol, Geneviève, Rossi, Jean-François
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ferrata Storti Foundation 2011
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3046271/
https://ncbi.nlm.nih.gov/pubmed/21109686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.029520
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk